Recent Finacing
Recent Raise
Prellis Biologics develops holographic two‑photon 3D bioprinting to fabricate high‑resolution vascularized tissue scaffolds and lymph‑node organoids (EXIS) for antibody discovery, drug screening, and implantable tissue research.
